Bausch Health Companies (BHC) EBIAT (2016 - 2025)
Historic EBIAT for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $181.0 million.
- Bausch Health Companies' EBIAT rose 29673.91% to $181.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $341.0 million, marking a year-over-year increase of 26553.4%. This contributed to the annual value of -$72.0 million for FY2024, which is 8821.6% up from last year.
- According to the latest figures from Q3 2025, Bausch Health Companies' EBIAT is $181.0 million, which was up 29673.91% from $148.0 million recorded in Q2 2025.
- Bausch Health Companies' 5-year EBIAT high stood at $403.0 million for Q3 2022, and its period low was -$610.0 million during Q1 2021.
- Over the past 5 years, Bausch Health Companies' median EBIAT value was -$69.0 million (recorded in 2022), while the average stood at -$84.6 million.
- Per our database at Business Quant, Bausch Health Companies' EBIAT plummeted by 71304.35% in 2022 and then skyrocketed by 138000.0% in 2025.
- Bausch Health Companies' EBIAT (Quarter) stood at $69.0 million in 2021, then crashed by 713.04% to -$423.0 million in 2022, then skyrocketed by 88.89% to -$47.0 million in 2023, then skyrocketed by 308.51% to $98.0 million in 2024, then skyrocketed by 84.69% to $181.0 million in 2025.
- Its last three reported values are $181.0 million in Q3 2025, $148.0 million for Q2 2025, and -$86.0 million during Q1 2025.